Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Solid Tumors × amivantamab × Thoracic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Other solid neoplasm 1

Conditions

Carcinoma, Non-Small-Cell Lung 19 Solid Tumors 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Metastatic Non-small Cell Lung Cancers 1 Lung Neoplasms 1 Head and Neck Neoplasms 1 Colorectal Neoplasms 1 Breast Neoplasms 1

Interventions

palbociclib 1 amivantamab 1 Tablets 1 CB-839 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06816992 2025-03-20

ORIC-114 in Combination with Subcutaneous Amivantamab in Patients with EGFR Exon20 Insertion Mutant NSCLC

ORIC Pharmaceuticals

Phase 1 Recruiting

Other solid neoplasmThoracic

Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡